Previously, HLA-G expression was reported in adult HL patients belonging to Ann Arbor stages IIb-IV in the tumor microenvironment in patients showing positron emission tomography (PET)-positive (carried out after 2 cycles of standard chemotherapy) during follow-up [37]. The gene discussed is HLA-G; the disease is neoplasm.